Post-Trial Tuberculosis Case Finding: A Substudy of CoVPN 3008
NCT06585683 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5694
Last updated 2026-01-26
Summary
This substudy aims to identify cases of tuberculosis after the CoVPN 3008 clinical trial is completed.
Conditions
Interventions
- DIAGNOSTIC_TEST
-
Clinical Evaluation at Day 4
Participants will undergo an abbreviated physical exam, assessment of concomitant medications, and reassessment for signs/symptoms of TB
- DIAGNOSTIC_TEST
-
Laboratory Evaluation at Day 4
Peripheral blood samples, including serum, PBMC, and whole blood, are collected from participants. A tongue swab is also collected from each participant.
- DIAGNOSTIC_TEST
-
Clinical Evaluation at week 26
Participants will undergo another complete physical exam and have their medical (including TB) history, potential TB signs/symptoms, and concomitant medications reassessed. Chest radiography will be obtained for all participants. An assessment of TB outcomes will also be performed.
- DIAGNOSTIC_TEST
-
Laboratory Evaluation at week 26
Peripheral blood samples, including serum, PBMC, and whole blood, will be collected. Participants not previously identified as living with HIV will undergo HIV diagnostic testing, while participants living with HIV will have their HIV viral load and CD4+ T-cell count measured.
Sponsors & Collaborators
-
National Institute of Allergy and Infectious Diseases (NIAID)
collaborator NIH -
Medical Research Council, South Africa
collaborator OTHER -
COVID-19 Prevention Network
lead NETWORK
Principal Investigators
-
Nigel Garrett · eThekwini CRS / Centre for the AIDS Programme of Research in South Africa (CAPRISA)
-
Philip Kotze · Qhakaza Mbokodo Research Clinic
-
Sufia Dadabhai · Blantyre CRS / Johns Hopkins Research Project
-
Nyaradzo Mgodi · University of Zimbabwe Clinical Trials Research Centre
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-09-13
- Primary Completion
- 2025-03-28
- Completion
- 2025-05-21
Countries
- Botswana
- Eswatini
- Kenya
- Malawi
- South Africa
- Uganda
- Zambia
Study Locations
More Related Trials
-
Study on Three Doses of an Inactivated COVID-19 Vaccine in Chinese Pulmonary Tuberculosis Patients
NCT05148949 ·Status: UNKNOWN ·Phase: PHASE4
-
Training Protocol on the Natural History of Tuberculosis
NCT01212003 ·Status: RECRUITING
-
DIAgnostics for Multidrug Resistant Tuberculosis in Africa
NCT03303963 ·Status: COMPLETED
-
Xpert Active Case-finding Trial 2: Community-based Active Case-finding for Tuberculosis in South Africa
NCT03168945 ·Status: COMPLETED ·Phase: NA
-
Test to Treat TB: Impact of Sputum Sequencing-guided Individualised Therapy on Outcomes in Drug-resistant Tuberculosis
NCT05007795 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Faster Identification of TB and Evaluation of Drug Resistance in HIV-infected People
NCT00959088 ·Status: COMPLETED
-
Prospective Evaluation of Novel Diagnostics for Tuberculosis in KwaZulu-Natal, South Africa
NCT04583904 ·Status: COMPLETED
-
Time-to-Detection in Culture of Mycobacterium Tuberculosis
NCT05568368 ·Status: COMPLETED
-
Evaluating Accuracy, Impact, and Operational Challenges of GeneXpert Use for TB Case Finding Among HIV-infected Persons
NCT02538952 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Study of Recombinant Mycobacterium Tuberculosis Fusion Protein for 65-year-olds and Above
NCT05899179 ·Status: COMPLETED ·Phase: PHASE3
-
TB Sequel: Pathogenesis and Risk Factors of Long-term Sequelae of Pulmonary TB
NCT03251196 ·Status: UNKNOWN
-
Rapid Research in Diagnostics Development for TB Network
NCT04923958 ·Status: RECRUITING ·Phase: NA
-
The Utility of Intensified Case Finding Combined With a Package of Novel TB Diagnostics Using a Mobile Clinic in Africa
NCT01990274 ·Status: COMPLETED ·Phase: NA
-
Effect of SARS-CoV-2 Disease on Immune Responses, Disease Severity and Treatment Outcomes in Pulmonary Tuberculosis
NCT04930978 ·Status: RECRUITING
-
Study of Limited Versus Continuous Isoniazid Tuberculosis Preventive Therapy in HIV-infected Persons in Botswana
NCT00164281 ·Status: COMPLETED ·Phase: PHASE4
-
Host Blood RNA Signatures for Diagnosis of TB
NCT05542511 ·Status: ACTIVE_NOT_RECRUITING
-
Acceptability and Feasibility of Home-based TB Testing
NCT04973371 ·Status: COMPLETED ·Phase: NA
-
TuBerculosis Viability Interregional Study and Agreement on Biological Tests
NCT04968886 ·Status: UNKNOWN
-
Utility of MODS for Diagnosis of MDR-TB and Second-Line Antituberculous Drug Susceptibility Testing in Mali
NCT01381757 ·Status: TERMINATED
-
Testing Health Workers At Risk to Advance Our Understanding of TB Infection
NCT06221488 ·Status: RECRUITING
-
A Registry of Tuberculosis Cases in the CPCRA
NCT00000785 ·Status: COMPLETED
-
Substudy of Protocol TB-018 (NCT01755598): Collection and Storage of Biological Samples for Evaluation of Correlates of TB (C-041-972)
NCT02097095 ·Status: COMPLETED
-
PanACEA - STEP2C -01
NCT05807399 ·Status: RECRUITING ·Phase: PHASE2
-
Safety Study Investigating if Concomitant Injections of C-Tb and 2 T.U Tuberculin Affect Induration Responses
NCT01779102 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Shortened Regimens for Drug-susceptible Pulmonary Tuberculosis
NCT02901288 ·Status: UNKNOWN ·Phase: PHASE4